Dean Investment Associates LLC lowered its holdings in MetLife, Inc. (NYSE:MET – Free Report) by 11.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,702 shares of the financial services provider’s stock after selling 614 shares during the quarter. Dean Investment Associates LLC’s holdings in MetLife were worth $388,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in MET. MeadowBrook Investment Advisors LLC increased its stake in shares of MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 220 shares during the period. Carmichael Hill & Associates Inc. grew its position in MetLife by 131.9% during the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after buying an additional 186 shares during the period. Wolff Wiese Magana LLC grew its position in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after buying an additional 277 shares during the period. Peterson Financial Group Inc. acquired a new stake in MetLife during the third quarter valued at $30,000. Finally, Fortitude Family Office LLC grew its position in MetLife by 177.3% during the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after buying an additional 266 shares during the period. Institutional investors and hedge funds own 94.99% of the company’s stock.
MetLife Stock Performance
NYSE:MET opened at $85.22 on Monday. The company’s 50-day moving average price is $83.79 and its 200-day moving average price is $77.06. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The company has a market cap of $59.01 billion, a P/E ratio of 17.18, a P/E/G ratio of 0.78 and a beta of 1.06. MetLife, Inc. has a twelve month low of $63.19 and a twelve month high of $89.05.
MetLife Dividend Announcement
Wall Street Analysts Forecast Growth
Several research firms recently commented on MET. Morgan Stanley dropped their price target on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research report on Monday, August 19th. TD Cowen raised their price target on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research report on Wednesday, November 27th. Piper Sandler raised their price target on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Jefferies Financial Group raised their price target on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. Finally, Barclays decreased their price objective on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Thursday, October 31st. Fourteen equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $88.62.
Check Out Our Latest Research Report on MET
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
- Five stocks we like better than MetLife
- Profitably Trade Stocks at 52-Week Highs
- Guidewire Software Provides Long-Awaited Buying Opportunity
- What Does Downgrade Mean in Investing?
- What’s Behind These 3 Recent Analyst Stock Upgrades?
- Using the MarketBeat Dividend Yield Calculator
- Fast-Growing Companies That Are Still Undervalued
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.